Since 2013, we have brought our innovative testing platforms to many industries and people, as part of our mission to make accurate health testing available anytime, anywhere.

Our Vision

To develop and commercialise novel technology for digital, point-of-care and lab-based diagnostic testing to hospitals, clinics, corporates and the end consumer. With our portfolio of health and clinical tests, we aim to bring health testing and real time health data to you anytime, anywhere.

What We Do

We develop rapid and non-invasive health testing based on our diagnostics and microfluidics platforms, seeking to transform the healthcare diagnostics space and enable ideal personalsed health for all.

Our Story

Since 2013, we have brought our innovative testing platforms to many applications and people, as part of our mission to make accurate health testing available anytime, anywhere.
Our detection platforms provide the basis for reliability, customisation and scalability in delivering rapid testing solutions. Based on these platforms we have brought to market a range of products for biodefence, food safety and clinical diagnostics applications, that disrupt current health testing workflows.
Having built significant R&D and manufacturing capabilities since 2013, our R&D is carried out at our laboratories in Cambridge, UK and Singapore, alongside ISO certified manufacturing facilities in Germany and Singapore. Our continual and long term investment in innovation allows us to meet rapidly evolving market requirements and provide best in class solutions.

Our Partners

Team Members

Dr Meng Han Kuok
CEO
MengHan received a BA and Masters in Engineering, followed by a PhD in BioEngineering from the University of Cambridge, where he worked on the application of novel biosensors for rapid anthrax detection. This research work resulted in a granted international patent in microfluidics and was subsequently spun out into Camtech Diagnostics and developed into the first lab-on-chip device for rapid anthrax detection.
He has more than 15 years experience in R&D, entrepreneurship and startup investment, and his previous commercial experience includes technology M&A, technology strategy consulting for governments and corporates, as well as advising biotech/ early stage venture capital funds.
With a keen passion to bring forward disruptive innovations in healthcare and biotech, his aim is to develop novel point-of-care diagnostic tests to bring the widest benefit to human health and well being.

Dr Deny Hartono
Technical and Operations Director
B.Eng. (First Class Honours) in Chemical Engineering from the Institut Teknologi Bandung and Ph.D. in Chemical and Biomolecular Engineering from the National University of Singapore. Deny has more than 15 years of R&D experience in the chemical and bio-sensor and microfluidic field. He holds 2 patents and has authored more than 20 technical papers in reputable international peer-reviewed journals, with more than half of his publications are in scientific journals with impact factor more than 5. Deny leads the technical development team in Camtech Diagnostics

Dr Daniel Kirilly
Director of Innovation/ Chief Scientific Officer
Daniel earned his PhD at the University of Kansas Medical Center, USA, focusing on stem cell biology. He was then awarded a Singapore Millennium Foundation fellowship to continue his work on cell and neurobiology in Singapore at the Temasek Lifesciences Laboratory Singapore. During his academic career he published in prestigious papers such as Nature Neuroscience and Developmental Cell. A decade ago he ventured into the commercial world and spent several years in Asia and Europe in startup companies at the senior executive and technical levels.

Dr Ana Zeng
VP Technical & Product Development, Food Safety
PhD in Molecular Microbiology from the Key Laboratory of Synthetic Biology, Chinese Academy of Sciences. Ana has 12 years of experience in R&D, Product Development and Project Management, with a key focus on biodetection in food safety enabling customized detection and traceability in food, as well as developing early detection methods combined with AI and big data analysis. She has several granted patents in enzyme/ food safety detection.

Nyi Nyi Lwin
QA/RA Manager
Nyi earned a bachelor’s degree from the University of Yangon and a Postgraduate diploma from the National University of Singapore.
He has over 20 years of experience in quality and regulatory management in the pharmaceutical and medical device industries, and has had responsibility for global regulatory activities for a variety of IVD and medical device. His experience covers a broad range of medical devices and all major medical device processes in the US, Europe, Canada, Middle East, China, India, Japan, and ASEAN.

Dr Gopal Ammanath
Senior Research Scientist
Gopal obtained his PhD in Biomedical Engineering from Nanyang Technological University in 2019, where he developed novel point of care (POC) diagnostic devices for oxidative stress biomarkers utilizing conjugated polymers. He then carried out postdoctoral research in IIT Delhi.
Gopal has a keen interest in biosensors and spectrophotometry, as well as developing paper based microfluidics and biosensors.
He oversees assay development at Camtech, focusing on developing paper based optical sensing platforms for different types of sample matrices, as well as lateral flow assays for various infectious diseases.

Dr Mun Fai Loke
Laboratory Research Director
Mun Fai earned a PhD in Microbiology from the Yong Loo Lin School of Medicine, National University of Singapore and an MBA from the University of Queensland. He has a Diploma in Data Science (Artificial Intelligence) from Singapore Polytechnic and is certified in Professional Biorisk Management (recognized by the Singapore Ministry of Health). He is an active member of the American Society of Microbiology, Singapore Association of Medical Laboratory Sciences, and Association of Biomedical Laboratory Professionals (Singapore).
Prior to joining Camtech, he held Postdoctoral and Principal Investigator Research positions at Singapore General Hospital, National University of Singapore, Temasek Polytechnic, University of Malaya, KK Women's and Children's Hospital, and Ngee Ann Polytechnic.
He is leading our laboratory development efforts to apply “omics” approaches using Next-Generation Sequencing and Mass Spectrometry in the areas of infectious diseases, rare diseases, cancers, human microbiome, and agri- and aquaculture microbiome.

Dr Xenia Lin Lim
Research Scientist
Xenia is a molecular biologist with a keen interest in diagnostics. She trained at Osaka University for her Ph.D., where she focused on molecular genetics and stem cell biology. She works on the development and application of novel diagnostics tool platforms that will transform Next Generation Sequencing workflows.

Nadelyn Chua
QA/RA Executine
Graduating from the National University of Singapore with a Bachelor in Science (Pharmacy), Nadelyn underwent training to become a registered pharmacist with the Singapore Pharmacy Council (SPC). Her foray into healthcare began at the frontlines: both retail and hospital pharmacies. She later joined the Provider Network advisory for a Third-Party Administrator (TPA) and procurement department for therapeutic drugs and medical devices, exposing her to medical devices and IVDs at various points in the products’ lifecycle.

Trusted By